From: Comparing drug safety of hepatitis C therapies using post-market data
FAERS
EHR
Old
New
N
43120
5307
820
4363
Age
53.1 (sd = 10.8)
58.1 (sd = 10.2)
51.8(sd =16.8)
47.3(sd =13.1)
Gender (Male%)
55.5%
56.7%
45.1%
63.4%